Worldwide approval for Cushing syndrome drug (1)

19 Nov 2019


Osilodrostat has been approved for use worldwide in the treatment of adults with Cushing syndrome.

Medscape


Related Topics

Adrenal Diabetes Metabolism Obesity Cardiovascular Bone Endocrine-Disrupting Chemicals Endocrine-Related Cancer Neuroendocrinology Reproduction Steroid and Steroidogenesis Thyroid

Share this story